Literature DB >> 32596863

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

Lars L F G Valke1,2, Erik A M Beckers2,3, Nicole M A Blijlevens1, Waander L van Heerde1,2,4, Saskia E M Schols1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32596863     DOI： 10.1111/hae.14085

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

Review 1.  Clinical use of thrombin generation assays.

Authors:  Nikolaus B Binder; François Depasse; Julia Mueller; Thomas Wissel; Stephan Schwers; Matthias Germer; Björn Hermes; Peter L Turecek
Journal:  J Thromb Haemost       Date:  2021-10-08       Impact factor: 16.036

Review 2.  Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.

Authors:  Marieke J A Verhagen; Lars L F G Valke; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2022-01-28       Impact factor: 16.036

3.  Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.

Authors:  Lars L F G Valke; Laura H Bukkems; Wideke Barteling; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Ron A A Mathôt; Waander L van Heerde; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2020-10-21       Impact factor: 16.036
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.